Advanced Cell Technology looks to Open Strong After Stem Cell Study

Advanced Cell Technology (ACTC) announced positive results of its retinal regeneration study in rats utilizing embryonic stem cells.

The company's stock already made a huge jump a few weeks ago after it announced that it had derived embryonic stem cells in an ethical way by taking a single cell from an embryo and harvesting it.

So look for a similar jump start of trading today.

_